Tirzepatide, a innovative medication, is generating significant interest in the medical community as a possible treatment for both type 2 diabetes and weight loss . This groundbreaking drug works by targeting two distinct receptors, GLP-1 and GIP, leading to better glucose control and substantial weight reduction in clinical trials . While initial